Expertise in
12
conditions

Emma L. Culver

Oxford, ENG, GB 
Expertise in
12
conditions
Oxford, ENG, GB 

Overview

Emma Culver practices practicing medicine in Oxford, United Kingdom.

Ms. Culver is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses IgG4-Related Disease, Cholangitis, Sclerosing Cholangitis, Primary Biliary Cholangitis, and Endoscopy.

She is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Oxford, ENG, United Kingdom
Other Locations
Pond Street, London, ENG NW32QG, United Kingdom
Reading, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid
A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid
Enrollment Status: Terminated
Publish Date: July 16, 2026
Intervention Type: Drug
Study Drugs: Obeticholic Acid, Bezafibrate
Study Phase: Phase 2
View 1 Less Clinical Trial

87 Total Publications

Obexelimab for the Treatment of IgG4-Related Disease.
Obexelimab for the Treatment of IgG4-Related Disease.
Journal: The New England journal of medicine
Published: June 03, 2026

Frequently Asked Questions about Emma L. Culver

Is Emma L. Culver a top-rated expert for IgG4-Related Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Emma L. Culver is classified as an Elite expert for IgG4-Related Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emma L. Culver participate in research or clinical trials?

Yes. Emma L. Culver has published 87 articles and abstracts on conditions like IgG4-Related Disease. You can view a list of Emma L. Culver's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Culver's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile